Results 1 to 10 of about 12,511 (199)
Optimization of Albuterol Delivery via Anesthesia Bag in Pediatric Critical Care [PDF]
Background/Objectives: Aerosolized medications are common practice for mechanically ventilated pediatric patients. Infants often receive nebulized medications via hand ventilation using an anesthesia bag, but evidence on optimal aerosol delivery with ...
Sébastien Tessier+5 more
doaj +2 more sources
Albuterol, Acidosis, and Aneurysms [PDF]
A patient with a complicated medical history on admission for dyspnea was administered nebulizer therapy but after 72 hours developed asymptomatic acute kidney injury and anion-gap metabolic acidosis.
Lucy Ma+2 more
openaire +3 more sources
Dexmedetomidine as an adjunctive treatment for acute asthma [PDF]
Objective This study aimed to compare the efficacy of using dexmedetomidine with salbutamol and salbutamol nebulization alone in patients with acute exacerbation of asthma presenting to the emergency department.
Hassan Motamed+3 more
doaj +1 more source
Albuterol-induced Lactic Acidosis [PDF]
Edwin B. Liem+2 more
openalex +4 more sources
Background Oral albuterol has worse efficacy and side effects compared with inhaled albuterol, and thus its use has been discouraged for decades. Drug inclusion or exclusion on formularies have been associated with reductions in low-value care.
Anna Volerman+4 more
doaj +1 more source
β2-Agonists inhibit TNF-α-induced ICAM-1 expression in human airway parasympathetic neurons. [PDF]
Major basic protein released from eosinophils to airway parasympathetic nerves blocks inhibitory M(2) muscarinic receptors on the parasympathetic nerves, increasing acetylcholine release and potentiating reflex bronchoconstriction.
Zhenying Nie+2 more
doaj +1 more source
Epigenomic response to albuterol treatment in asthma-relevant airway epithelial cells
Background Albuterol is the first-line asthma medication used in diverse populations. Although DNA methylation (DNAm) is an epigenetic mechanism involved in asthma and bronchodilator drug response (BDR), no study has assessed whether albuterol could ...
Javier Perez-Garcia+16 more
doaj +1 more source
Objective Albuterol is a β2‐agonist and causes an intracellular shift of potassium from the interstitium. Whole‐body hypokalemia is known to cause skeletal muscle weakness, but whether this occurs as a result of hypokalemia from the intracellular shift ...
Catherine Burger+2 more
doaj +1 more source
Nebulized heparin and salbutamol versus salbutamol alone in acute exacerbations of chronic obstructive pulmonary disease requiring mechanical ventilation: a double-blind randomized controlled trial [PDF]
Background Nebulized heparin has been effectively used in the management of many pulmonary diseases. However, its effect on mechanically ventilated patients with acute exacerbation chronic obstructive pulmonary disease (AECOPD) has never been studied ...
Tarek Mohamed Ashoor+2 more
doaj +1 more source
Preferential Pulmonary Retention of (S)-Albuterol after Inhalation of Racemic Albuterol [PDF]
The (R)-enantiomer of racemic albuterol produces bronchodilation, whereas the (S)-enantiomer may increase airway reactivity. After oral or intravenous administration of racemic albuterol, the (R)- enantiomer is metabolized several times faster than the (S)-enantiomer; however, enantiomer disposition after inhaling racemic albuterol with a metered-dose ...
Mark L. Goode+5 more
openaire +3 more sources